The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Int J Mol Sci. 2018 Mar 31;19(4):1045. doi: 10.3390/ijms19041045.
Annexin A1 (ANXA1) has long been classed as an anti-inflammatory protein due to its control over leukocyte-mediated immune responses. However, it is now recognized that ANXA1 has widespread effects beyond the immune system with implications in maintaining the homeostatic environment within the entire body due to its ability to affect cellular signalling, hormonal secretion, foetal development, the aging process and development of disease. In this review, we aim to provide a global overview of the role of ANXA1 covering aspects of peripheral and central inflammation, immune repair and endocrine control with focus on the prognostic, diagnostic and therapeutic potential of the molecule in cancer, neurodegeneration and inflammatory-based disorders.
膜联蛋白 A1(ANXA1)长期以来一直被归类为抗炎蛋白,因为它可以控制白细胞介导的免疫反应。然而,现在人们认识到,ANXA1 的作用不仅限于免疫系统,它还通过影响细胞信号转导、激素分泌、胎儿发育、衰老过程和疾病的发展,对全身的内稳态环境产生广泛的影响。在这篇综述中,我们旨在提供 ANXA1 作用的全面概述,涵盖外周和中枢炎症、免疫修复和内分泌控制等方面,重点介绍该分子在癌症、神经退行性疾病和炎症性疾病中的预后、诊断和治疗潜力。